# A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

> **NCT07645924** · PHASE3 · RECRUITING · sponsor: **Kallyope Inc.** · enrollment: 1800 (estimated)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Elismetrep
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07645924
- **Lead sponsor:** Kallyope Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2026-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07645924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07645924, "A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07645924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*